Stunning effects after a diagnostic dose of iodine-131

Nuklearmedizin. 1998 Jan;37(1):30-2.

Abstract

Aim: To understand stunning effects of a diagnostic dose of iodine-131 (I-131).

Methods: Four hundred and sixty-eight patients (101 males, 367 females, ages: 6-75 years with well differentiated thyroid cancer, following total or nearly total thyroidectomy, were studied. One hundred and eleven MBq (3 mCi) diagnostic (Dx) doses of I-131 whole body scan (WBS) were obtained after withholding thyroxine after 6 weeks and triiodothyronine for 2 weeks. One week to one month later, 3.7-7.4 GBq (100-200 mCi) I-131 was given to them, then a therapeutic (Tx) dose of I-131 WBS was performed. The serum thyroid simulating hormone level was usually above muIU/ml.

Results: Of the 468 patients, 344 (73.5%) had scintigraphic patterns of apparently decrease uptake in 240 thyroid remnants and 104 metastatic lesions on the Tx dose of I-131 WBS compared to Dx dose of I-131 WBS. Stunning phenomenon occurred in 50 cases, including 42 thyroid remnants and 18 metastatic lesions.

Conclusion: Dx dose of I-131 may influence the uptake of a subsequently administered Tx dose of I-131.

MeSH terms

  • Adenocarcinoma, Follicular / diagnostic imaging
  • Adenocarcinoma, Follicular / radiotherapy
  • Adolescent
  • Adult
  • Aged
  • Carcinoma, Papillary / diagnostic imaging
  • Carcinoma, Papillary / radiotherapy
  • Child
  • Female
  • Follow-Up Studies
  • Humans
  • Iodine Radioisotopes / therapeutic use*
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Radiopharmaceuticals / therapeutic use*
  • Retrospective Studies
  • Thyroid Neoplasms / diagnostic imaging*
  • Thyroid Neoplasms / radiotherapy*
  • Time Factors
  • Tomography, Emission-Computed

Substances

  • Iodine Radioisotopes
  • Radiopharmaceuticals